People In The News | GenomeWeb

NEW YORK (GenomeWeb News) – Roche said this week that it has appointed Daniel O'Day, current COO of Roche Diagnostics, to be COO of Roche Pharma, taking over for Pascal Soriot, who has left the firm to become CEO of AstraZeneca. Roland Diggelmann will succeed O'Day as COO of Roche Diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.